Hui-Yuen JS - Search Results

1

Emerging B-Cell Therapies in Systemic Lupus Erythematosus.

Bag-Ozbek A, Hui-Yuen JS. Bag-Ozbek A, et al. Among authors: hui yuen js. Ther Clin Risk Manag. 2021 Jan 14;17:39-54. doi: 10.2147/TCRM.S252592. eCollection 2021. Ther Clin Risk Manag. 2021. PMID: 33488082 Free PMC article. Review.

2

TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease.

Hui-Yuen JS, Duong TT, Yeung RS. Hui-Yuen JS, et al. J Immunol. 2006 May 15;176(10):6294-301. doi: 10.4049/jimmunol.176.10.6294. J Immunol. 2006. PMID: 16670341

3

Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus.

Hui-Yuen JS, Nguyen SC, Askanase AD. Hui-Yuen JS, et al. Lupus. 2016 Sep;25(10):1086-96. doi: 10.1177/0961203316652491. Lupus. 2016. PMID: 27497253 Review.

4

Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab.

Guzman M, Hui-Yuen JS. Guzman M, et al. Among authors: hui yuen js. Drug Des Devel Ther. 2020 Jun 25;14:2503-2513. doi: 10.2147/DDDT.S216193. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32612353 Free PMC article. Review.

5

Belimumab in systemic lupus erythematosus: a perspective review.

Hui-Yuen JS, Li XQ, Askanase AD. Hui-Yuen JS, et al. Ther Adv Musculoskelet Dis. 2015 Aug;7(4):115-21. doi: 10.1177/1759720X15588514. Ther Adv Musculoskelet Dis. 2015. PMID: 26288663 Free PMC article. Review.

6

Chromatin landscapes and genetic risk in systemic lupus.

Hui-Yuen JS, Zhu L, Wong LP, Jiang K, Chen Y, Liu T, Jarvis JN. Hui-Yuen JS, et al. Arthritis Res Ther. 2016 Dec 1;18(1):281. doi: 10.1186/s13075-016-1169-9. Arthritis Res Ther. 2016. PMID: 27906046 Free PMC article.

7

Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity.

Hui-Yuen JS, Gartshteyn Y, Ma M, O'Malley T, Conklin J, Eichenfield AH, Imundo LF, Dervieux T, Askanase AD. Hui-Yuen JS, et al. Lupus. 2018 Dec;27(14):2262-2268. doi: 10.1177/0961203318809181. Epub 2018 Oct 30. Lupus. 2018. PMID: 30376789

8

Validation of the 2019 European League Against Rheumatism/American College of Rheumatology Criteria Compared to the 1997 American College of Rheumatology Criteria and the 2012 Systemic Lupus International Collaborating Clinics Criteria in Pediatric Systemic Lupus Erythematosus.

Ma M, Hui-Yuen JS, Cerise JE, Iqbal S, Eberhard BA. Ma M, et al. Among authors: hui yuen js. Arthritis Care Res (Hoboken). 2020 Nov;72(11):1597-1601. doi: 10.1002/acr.24057. Arthritis Care Res (Hoboken). 2020. PMID: 31478595

9

Discordant Perception of Disease Activity Between Providers and Adolescents with Systemic Lupus Erythematosus: A Cohort Study.

Mian Z, Calistro T, Rapoza K, Berkowitz SS, Rubinstein TB, Walters HM, Eberhard BA, Kenney-Riley K, Hui-Yuen JS. Mian Z, et al. Among authors: hui yuen js. J Pediatr. 2024 Nov;274:114216. doi: 10.1016/j.jpeds.2024.114216. Epub 2024 Jul 27. J Pediatr. 2024. PMID: 39074734 Free PMC article.

10

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.

Hui-Yuen JS, Reddy A, Taylor J, Li X, Eichenfield AH, Bermudez LM, Starr AJ, Imundo LF, Buyon J, Furie RA, Kamen DL, Manzi S, Petri M, Ramsey-Goldman R, van Vollenhoven RF, Wallace DJ, Askanase A. Hui-Yuen JS, et al. J Rheumatol. 2015 Dec;42(12):2288-95. doi: 10.3899/jrheum.150470. Epub 2015 Nov 1. J Rheumatol. 2015. PMID: 26523030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters